Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/17/3117225/0/en/Actuate-Therapeutics-Advances-Clinical-Program-in-Ewing-Sarcoma-After-Positive-Phase-1-Trial-Demonstrates-Complete-and-Partial-Responses-in-Difficult-to-Treat-Pediatric-Sarcomas.html
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104339/0/en/Actuate-Therapeutics-Highlights-Significant-and-Sustained-Survival-Benefit-in-Key-Metastatic-Pancreatic-Cancer-Patient-Populations-in-Phase-2-Elraglusib-Trial.html
20 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/20/3102706/0/en/Actuate-Therapeutics-Reports-Positive-Biomarker-and-Machine-Learning-Data-from-Phase-2-Elraglusib-Trial-in-First-Line-Treatment-of-Metastatic-Pancreatic-Cancer-at-ASCO.html
16 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/16/3099814/0/en/Actuate-Therapeutics-Announces-Inclusion-in-the-Russell-3000-and-Russell-2000-Indexes.html
03 Jun 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/asco-actuates-pancreatic-cancer-drug-boost-survival-3-months-phase-2-study
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3091936/0/en/Actuate-Therapeutics-Shares-Highlights-from-KOL-Event-on-Positive-Topline-Elraglusib-Phase-2-Data-in-First-Line-Treatment-of-Metastatic-Pancreatic-Cancer.html
ABOUT THIS PAGE